Organization
Genfit
4 clinical trials
Clinical trial
An Open-label, Phase 1, Multiple-dose Study to Evaluate the Pharmacokinetics of Nitazoxanide 500 mg Twice Daily for 7 Days in Adult Subjects With Mild, Moderate, and Severe Renal Impairment and Adult Healthy Control SubjectsStatus: Completed, Estimated PCD: 2022-09-04
Clinical trial
An Open-label, Phase 1, Multiple-dose Study to Evaluate the Pharmacokinetics of Nitazoxanide 500 mg Twice Daily for 7 Days in Adult Subjects With Moderate and Severe Hepatic Impairment and Adult Healthy Control SubjectsStatus: Completed, Estimated PCD: 2022-04-08
Clinical trial
A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).Status: Completed, Estimated PCD: 2015-02-01
Clinical trial
Phase 1b/2a Study of GNS561 in Combination With Trametinib in Advanced KRAS Mutated CholangiocarcinomaStatus: Recruiting, Estimated PCD: 2026-05-01